Literature DB >> 6015649

Effect of Lyndiol, an oral contraceptive, on breast cancer.

B A Stoll.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6015649      PMCID: PMC1840538          DOI: 10.1136/bmj.1.5533.150

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  5 in total

1.  ORAL CONTRACEPTIVES AND LIVER DAMAGE.

Authors:  B A STOLL; J T ANDREWS; R MOTTERAM; J UPFILL
Journal:  Br Med J       Date:  1965-03-13

2.  DELALUTIN AND ESTROGENS FOR THE TREATMENT OF ADVANCED MAMMARY CARCINOMA IN THE POSTMENOPAUSAL WOMAN.

Authors:  L G CROWLEY; I MACDONALD
Journal:  Cancer       Date:  1965-04       Impact factor: 6.860

3.  Estradiol benzoate and progesterone in advanced human-breast cancer. A combination found effective in advanced cases.

Authors:  R L LANDAU; E N EHRLICH; C HUGGINS
Journal:  JAMA       Date:  1962-11-10       Impact factor: 56.272

4.  Extinction of experimental mammary cancer. I. Estradiol-17beta and progesterone.

Authors:  C HUGGINS; R C MOON; S MORII
Journal:  Proc Natl Acad Sci U S A       Date:  1962-03-15       Impact factor: 11.205

5.  Post-menopausal oestrogen production.

Authors:  R A STRUTHERS
Journal:  Br Med J       Date:  1956-06-09
  5 in total
  4 in total

Review 1.  Current status of the management of patients with endocrine-sensitive tumors. I. Introduction and carcinoma of the breast.

Authors:  L G Crowley
Journal:  Calif Med       Date:  1969-01

Review 2.  Clinical practice guidelines for the care and treatment of breast cancer: 14. The role of hormone replacement therapy in women with a previous diagnosis of breast cancer.

Authors:  Kathleen I Pritchard; Humaira Khan; Mark Levine
Journal:  CMAJ       Date:  2002-04-16       Impact factor: 8.262

3.  Cancer hazards of the pharmacy.

Authors:  G M Bonser
Journal:  Br Med J       Date:  1967-10-28

Review 4.  Physiologic effects of steroid hormones and postmenopausal hormone replacement on the female breast and breast cancer risk.

Authors:  I A Mustafa; K I Bland
Journal:  Ann Surg       Date:  1998-11       Impact factor: 12.969

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.